dostarlimab
Combined Dostarlimab, Standard of Care Improves Survival for Endometrial Cancer Patients
Adding the PD-1 checkpoint inhibitor Jemperli to carboplatin and paclitaxel improves survival in patients with ...
MAY 13, 2023
100% Remission Rate ‘Thrills’ Rectal Cancer Investigators
A phase 2 study of patients with early-stage rectal cancer, conducted at Memorial Sloan Kettering Cancer ...
JUNE 8, 2022
Load more